Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 71335-0853

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 71335-0853). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713350853)

Label Image (Lbl713350853)
Label for Valsartan Hctz 320/25mg tablet packaged by Bryant Ranch Prepack in Burbank, CA. The label includes storage instructions to keep at room temperature (20°-25°C), a notice to keep drugs out of children's reach, and a barcode. The product compares to Diovan Hctz 320/25mg tablet by Alembic Pharmaceuticals Limited. The package contains 30 film-coated tablets.*
FDA Label Image

Figure 1 (Valsahctz Figur1)

Figure 1 (Valsahctz Figur1)
A line graph depicting the probability of achieving systolic blood pressure (SBP) less than 140 mmHg at Week 8, plotted against baseline SBP values ranging from 140 to 180 mmHg. The graph compares four groups: valsartan and hydrochlorothiazide tablets 320/25 mg, valsartan 320 mg, hydrochlorothiazide 25 mg, and placebo, indicating differing probabilities across baseline SBP levels.*
FDA Label Image

Figure 2-3-4 (Valsahctz Figure2 3 4)

Figure 2-3-4 (Valsahctz Figure2 3 4)
A set of three line graphs showing the probability of achieving target blood pressure levels at Week 8 for Valsartan and Hydrochlorothiazide tablets 320/25 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and placebo. The first graph plots % SBP <90 mmHg against baseline DBP (mmHg). The second shows % SBP <130 mmHg against baseline SBP (mmHg). The third graph shows % SBP <80 mmHg versus baseline DBP (mmHg). Each graph includes a legend with distinct markers for each treatment group.*
FDA Label Image

Structure (Valsahctz Hctz)

Structure (Valsahctz Hctz)
Chemical structure diagram of the active ingredient shown, representing the molecular structure of the compound. The image includes chemical bonds and atoms including chlorine, nitrogen, oxygen, and sulfur groups.*
FDA Label Image

Structure (Valsahctz Valsa)

Structure (Valsahctz Valsa)
Chemical structure of the active ingredient Valsartan, showing its molecular composition with rings and functional groups relevant to its pharmaceutical properties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.